Chlamydia and Chlamydophila
On this page
Direct answer
Two morphological forms define this family of obligate intracellular bacteria: the small, dense, extracellular elementary body that infects, and the larger, metabolically active reticulate body that divides within a host-cell inclusion. Chlamydia trachomatis serovars A-C cause trachoma, the world's leading infectious blindness, which India's national surveys have now pushed to elimination levels; serovars D-K cause genital infection, neonatal conjunctivitis and pelvic inflammatory disease; serovars L1-L3 cause lymphogranuloma venereum. Chlamydophila pneumoniae (TWAR strain) produces atypical pneumonia and Chlamydophila psittaci psittacosis from birds. Because the cell wall lacks muramic acid and the organism pirates host ATP, beta-lactams are useless and tetracyclines or macrolides are the treatment; nucleic acid amplification is the diagnostic standard.
What you must remember
- Structure: gram-negative-like envelope but no classic peptidoglycan — muramic acid is absent, so penicillins and cephalosporins cannot act; energy parasites dependent on host ATP.
- Life cycle: elementary body endocytosed → reorganises into reticulate body → binary fission within an inclusion over 48-72 hours → condenses back into elementary bodies released on cell rupture.
- Staining hallmark: C. trachomatis inclusions contain glycogen and stain brown with iodine or with Lugol's solution — a rapid, bench-level differentiator from other chlamydiae.
- Serovar map: A-C trachoma; D-K urogenital and neonatal disease; L1-L3 lymphogranuloma venereum with suppurating inguinal nodes and the historic Frei skin test.
- Other Chlamydophila: C. pneumoniae (TWAR) — atypical pneumonia in the young, serologically linked to atherosclerosis; C. psittaci — psittacosis from parrots and poultry, where the bird contact history outweighs any single test.
- Diagnosis: NAAT (including CBNAAT platforms used in Indian laboratories) is first line for genital and ocular specimens; culture on McCoy or HeLa cells (with cycloheximide) is the traditional reference; direct fluorescent antibody and microimmunofluorescence serology retain niche roles.
- Treatment: doxycycline or azithromycin for adult infection; neonatal chlamydial conjunctivitis and pneumonia need oral erythromycin or azithromycin — topical treatment alone is inadequate because carriage persists.
- Public health: the SAFE strategy (Surgery, Antibiotics, Facial cleanliness, Environmental improvement) under WHO trachoma elimination; Indian national trachoma surveys from 2014-2017 documented elimination-level prevalence.
Why the life cycle dictates every fact
Every examination-worthy property of chlamydiae is a consequence of their cycle. The elementary body is metabolically inert and built for survival outside cells — that is the form transmitted sexually, perinatally and by flies in trachoma. Once inside an endocytic vacuole it converts to the reticulate body, which cannot make its own ATP and draws on the host — hence "energy parasites", hence also the target of therapy: tetracyclines and macrolides act on the protein synthesis that fuels reticulate-body division, while beta-lactams find no peptidoglycan to attack. The 48-72 hour cycle explains why cultures must be held, why inclusions grow visibly before they burst, and why the glycogen-packed inclusions of C. trachomatis alone take up iodine.
The cycle also organises diagnosis. Culture needs living monolayers because chlamydiae replicate nowhere else — technically demanding, which is why NAAT, unfussy about viability, has displaced it for genital infection screening. Serology with microimmunofluorescence still distinguishes species-specific antibody when NAAT is unavailable. At the bedside, apply the serovar map: a newborn with conjunctivitis in week two or three of life has serovars D-K acquired at delivery, while a villager with pannus and corneal scarring carries serovars A-C from childhood; a man with matted inguinal buboes and a draining fistula completes the picture with L1-L3. One species, three clinical universes, all navigated by the same intracellular cycle.
High-yield viva angles
Examiners relish the comparison between neonatal chlamydial and gonococcal conjunctivitis: gonococcal strikes within two to five days with profuse purulent discharge, chlamydial after one to three weeks with milder, persistent conjunctivitis or a staccato pneumonia at six weeks — timing is the discriminator. The iodine-stained inclusion earns its own question, as does the species that lacks glycogen inclusions (Chlamydophila). Expect "why is penicillin ineffective despite gram-negative staining?" — answer with muramic-acid-free cell walls, not with beta-lactamase. The Indian angle is strong: national trachoma surveys from 2014 to 2017 showed elimination as a public health problem, a quotable programme success built on the SAFE strategy, and psittacosis questions usually hide the pet parrot in the history's last line.
Frequently asked questions
What is the difference between elementary and reticulate bodies?
Elementary bodies are small, dense, infectious extracellular forms; reticulate bodies are larger, dividing forms inside the inclusion that reorganise into elementary bodies for release.
Why are beta-lactams ineffective against chlamydiae?
Their cell walls lack peptidoglycan and muramic acid, removing the target that penicillins and cephalosporins require.
Which serovars cause lymphogranuloma venereum?
Serovars L1, L2 and L3 of Chlamydia trachomatis, producing inguinal buboes, fistulae and the historic Frei test positivity.
What is the diagnostic test of choice for genital chlamydial infection?
Nucleic acid amplification testing on first-void urine or swabs, now including CBNAAT platforms available in Indian reference laboratories.
What does the SAFE strategy stand for?
Surgery for trichiasis, Antibiotics, Facial cleanliness and Environmental improvement — the WHO package that carried trachoma toward elimination, including in India.